AstraZeneca acquires infant US biotech company

AstraZeneca, the pharmaceutical and biologics company, has purchased US biotechnology firm AlphaCore Pharma. The small operation focuses on heart treatments, and is developing treatments for the orphan disease familial LCAT deficiency (FLD) and the acute treatment of atherosclerosis.